Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
46.49M | 78.45M | 78.26M | 57.61M | 110.07M | Gross Profit |
4.01M | 10.45M | 22.97M | 15.12M | 37.26M | EBIT |
-28.41M | -25.67M | 2.54M | -1.84M | 25.47M | EBITDA |
-25.43M | -22.70M | 2.56M | 897.00K | 22.08M | Net Income Common Stockholders |
-29.79M | -24.42M | 604.00K | -483.00K | 17.16M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
25.50M | 50.91M | 70.05M | 79.86M | 84.82M | Total Assets |
95.37M | 124.68M | 147.83M | 145.76M | 153.09M | Total Debt |
6.01M | 987.00K | 2.18M | 1.04M | 2.05M | Net Debt |
-16.92M | -47.31M | -65.33M | -71.04M | -82.77M | Total Liabilities |
11.74M | 11.12M | 9.85M | 8.38M | 15.22M | Stockholders Equity |
83.63M | 113.57M | 137.99M | 137.38M | 137.87M |
Cash Flow | Free Cash Flow | |||
-18.28M | -13.75M | -870.00K | -10.64M | 17.94M | Operating Cash Flow |
-17.68M | -13.63M | -771.00K | -10.62M | 18.91M | Investing Cash Flow |
-3.67M | -4.33M | -2.59M | 1.96M | -964.00K | Financing Cash Flow |
-3.89M | -1.25M | -1.20M | -1.10M | -561.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | HK$46.87B | 10.87 | 9.62% | 2.73% | 11.54% | 16.09% | |
71 Outperform | $60.64B | 6.18 | 14.62% | 7.58% | 1.21% | 2.15% | |
68 Neutral | HK$12.43B | 12.56 | 7.25% | 4.98% | -1.81% | -3.79% | |
64 Neutral | $4.28B | 11.80 | 5.33% | 250.46% | 4.10% | -9.26% | |
43 Neutral | HK$125.40M | ― | -26.96% | ― | -45.45% | 15.77% | |
39 Underperform | €175.76M | 1.79 | ― | 41.43% | ― | ||
33 Underperform | €187.81M | ― | ― | -15.39% | 19.69% |